Reductions in hospitalisations and emergency department visits with early antibiotic initiation in nontuberculous mycobacterial lung disease

被引:0
|
作者
Winthrop, Kevin [1 ,2 ]
Waweru, Catherine [3 ]
Hassan, Mariam [3 ]
Burns, Sara [4 ]
Lucci, Matthew [4 ]
Chatterjee, Anjan [3 ]
机构
[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[2] Portland State Univ, Sch Publ Hlth, Portland, OR 97207 USA
[3] Insmed Inc, Bridgewater Township, NJ USA
[4] Panalgo, Boston, MA USA
关键词
PULMONARY-DISEASE; AVIUM COMPLEX; DIAGNOSIS; MORTALITY; IMPACT;
D O I
10.1183/23120541.00963-2023
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background While antibiotics are recommended for treatment of nontuberculous mycobacterial lung disease (NTMLD), the impact of early antibiotic initiation on healthcare resource utilisation is unclear. This study compared healthcare resource utilisation with early versus delayed antibiotic initiation in NTMLD. Methods A retrospective, claims database study (Merative MarketScan) of patients diagnosed with NTMLD between 1 July 2015 and 30 June 2019. Patients were divided into early antibiotic initiation, i.e. <= 3 months after the first medical claim for NTMLD (index date), and delayed antibiotic initiation groups. Hospitalisations and outpatient visits during a 2-year post-index period were compared to baseline per treatment group; a difference-in-difference analysis compared early and delayed antibiotic initiation groups adjusting for confounding. Results Out of 481 NTMLD treated patients, 364 (76%) and 117 (24%) comprised the early and delayed antibiotic initiation groups, respectively. The early antibiotic initiation group showed significant reductions from baseline in hospitalisations (all-cause, respiratory) and emergency department (ED) visits at follow-up. A significant increase from baseline in mean number of hospitalisations per patient was observed in the delayed antibiotic initiation group in year 1 post-index. Compared to delayed antibiotic initiation, the early antibiotic initiation group showed significantly greater reductions in all-cause hospitalisations in years 1 and 2 post-index (relative risk 0.62 (95% CI 0.41-0.95) and 0.62 (95% CI 0.39-0.98), respectively), and in respiratory-related hospitalisations. Conclusions The early antibiotic initiation group showed significant reductions from baseline in hospitalisations and ED visits over time. Compared to delayed antibiotic initiation, early antibiotic initiation was associated with significantly greater reductions in hospitalisations.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Antibiotic treatment for nontuberculous mycobacterial lung disease
    Kang, Young Ae
    Koh, Won-Jung
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2016, 10 (05) : 557 - 568
  • [2] Development of lung cancer in patients with nontuberculous mycobacterial lung disease
    Kusumoto, Tatsuya
    Asakura, Takanori
    Suzuki, Shoji
    Okamori, Satoshi
    Namkoong, Ho
    Fujiwara, Hiroshi
    Yagi, Kazuma
    Kamata, Hirofumi
    Ishii, Makoto
    Betsuyaku, Tomoko
    Hasegawa, Naoki
    RESPIRATORY INVESTIGATION, 2019, 57 (02) : 157 - 164
  • [3] Nontuberculous mycobacterial lung disease
    Griffith, David E.
    CURRENT OPINION IN INFECTIOUS DISEASES, 2010, 23 (02) : 185 - 190
  • [4] Time to Consider Treatment Initiation for Patients With Nontuberculous Mycobacterial Lung Disease
    Pan, Sheng-Wei
    Shu, Chin -Chung
    CHEST, 2022, 162 (04) : E203 - E204
  • [5] Is the Leicester Cough Questionnaire useful for nontuberculous mycobacterial lung disease?
    Takao, Satoshi
    Tabusadani, Mitsuru
    Yamane, Kazumasa
    Kakuta, Takeshi
    Kuroyama, Yuki
    Mori, Kosuke
    Ono, Kazuki
    Omatsu, Shunya
    Kawahara, Kazuma
    Toyoda, Yuki
    Senjyu, Hideaki
    RESPIRATORY INVESTIGATION, 2021, 59 (01) : 120 - 125
  • [6] Nonpharmacological treatment for patients with nontuberculous mycobacterial lung disease
    Lan, Chou-Chin
    Lai, Sheng-Ru
    Chien, Jung-Yien
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2020, 119 : S42 - S50
  • [8] Nontuberculous Mycobacterial Lung Disease Accompanied by Organizing Pneumonia
    Nakahara, Yasuharu
    Oonishi, Yasutaka
    Takiguchi, Junji
    Morimoto, Akie
    Matsuoka, Katsunari
    Imanishi, Naoko
    Higashino, Takanori
    Mimura, Rokuro
    Kawamura, Tetsuji
    Mochiduki, Yoshiro
    INTERNAL MEDICINE, 2015, 54 (08) : 945 - 951
  • [9] Clinicopathologic characteristics of nontuberculous mycobacterial lung disease in Taiwan
    Hsiao, Cheng-Hsiang
    Lin, Yi-Ting
    Lai, Chih-Cheng
    Hsueh, Po-Ren
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2010, 68 (03) : 228 - 235
  • [10] The Impact of Nontuberculous Mycobacteria Species on Mortality in Patients With Nontuberculous Mycobacterial Lung Disease
    Wang, Ping-Huai
    Pan, Sheng-Wei
    Wang, Su-Mei
    Shu, Chin-Chung
    Chang, Chin-Hao
    FRONTIERS IN MICROBIOLOGY, 2022, 13